highly significantP=0.002
ER/PR positive cancers, with and without Her2 expression, showed highly significant upregulated BCL9-2 ( P=0.002 and P<0.0001 , respectively; Fig. 1A, D ).
ER/PR positive cancers, with and without Her2 expression, showed highly significant upregulated BCL9-2 ( P=0.002 and P<0.0001 , respectively; Fig. 1A, D ).